Mark van der Linden
- Epidemiology top 0.5%
- Microbiology top 0.1%
- Public Health, Environmental and Occupational Health top 1%
- Infectious Diseases top 1%
- Molecular Medicine top 1%
- Co-authors
- Matthias ImöhlRalf René ReinertStephanie PerniciaroRüdiger von KriesAdnan Al‐LahhamSimon RückingerGerhard FalkenhorstRegine Hakenbeck
- Topics
- Pneumonia and Respiratory Infections (124 papers)Bacterial Infections and Vaccines (56 papers)Streptococcal Infections and Treatments (48 papers)
- Partner nations
- GermanyBelgiumUnited States
In The Last Decade
Mark van der Linden
199 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 121
- Epidemiology 3.1k
- Microbiology 1.3k
- Public Health, Environmental and Occupational Health 1.3k
- Infectious Diseases 1.1k
- Molecular Medicine 439
Countries citing papers authored by Mark van der Linden
This map shows the geographic impact of Mark van der Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark van der Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark van der Linden more than expected).
Fields of papers citing papers by Mark van der Linden
This network shows the impact of papers produced by Mark van der Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark van der Linden. The network helps show where Mark van der Linden may publish in the future.
Co-authorship network of co-authors of Mark van der Linden
This figure shows the co-authorship network connecting the top 25 collaborators of Mark van der Linden. A scholar is included among the top collaborators of Mark van der Linden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark van der Linden. Mark van der Linden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 55 | |
| 4 | 9 | |
| 5 | 3 | |
| 6 | 34 | |
| 7 | 26 | |
| 8 | 9 | |
| 9 | 15 | |
| 10 | 40 | |
| 11 | 62 | |
| 12 | 13 | |
| 13 | 5 | |
| 14 | 1 | |
| 15 | 7 | |
| 16 | 7 | |
| 17 | 8 | |
| 18 | 2 | |
| 19 | 1 | |
| 20 | 5 |
About Mark van der Linden
Mark van der Linden is a scholar working on Microbiology, Molecular Medicine and Epidemiology, having authored 203 papers that have together received 4.7k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (124 papers), Bacterial Infections and Vaccines (56 papers) and Streptococcal Infections and Treatments (48 papers). The work is most often cited by research in Microbiology (1.3k citations), Epidemiology (3.1k citations) and Molecular Medicine (439 citations). Mark van der Linden has collaborated with scholars based in Germany, Belgium and United States. Frequent co-authors include Matthias Imöhl, Ralf René Reinert, Stephanie Perniciaro, Rüdiger von Kries, Adnan Al‐Lahham, Simon Rückinger, Gerhard Falkenhorst, Regine Hakenbeck, E. Yourassowsky and Murat Cil. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.